AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ANASTROZOLE 1 Mg ;

13 registrations across 1 African market— 13 active

Markets with ANASTROZOLE 1 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Strazolan
Film Coated Tablets
🇪🇬EgyptATCO Pharma for Pharmaceutical Industriesactive
Anastrozole - Technopharma Egypt
Film Coated Tablets
🇪🇬EgyptTechnopharma egyptactive
Anastratreat
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Anastrozole Pharmacare
Film Coated Tablets
🇪🇬EgyptGlobe alliance medicaactive
Anastronate
Film Coated Tablets
🇪🇬EgyptHi Pharm for manufacturing pharmaceuticals and chemicalsactive
Strazolan
Film Coated Tablets
🇪🇬EgyptATCO Pharma for Pharmaceutical Industriesactive
Anastronate
Film Coated Tablets
🇪🇬EgyptHi Pharm for manufacturing pharmaceuticals and chemicalsactive
Anastratreat
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Anastrozole Pharmacare
Film Coated Tablets
🇪🇬EgyptGlobe alliance medicaactive
Arimidex®
Tablets
🇪🇬EgyptAstraZeneca Egypt for Pharmaceutical Industriesactive
Arimidex®
Tablets
🇪🇬EgyptAstraZeneca Egypt for Pharmaceutical Industriesactive
Anastrozol synthon
Film Coated Tablets
🇪🇬EgyptAboukir Trading for International Tradeactive
Anastrozole - Technopharma Egypt
Film Coated Tablets
🇪🇬EgyptTechnopharma egyptactive

ANASTROZOLE 1 Mg ; in Africa — Regulatory Overview

ANASTROZOLE 1 Mg ; is registered across 1 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 13 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.